Canadian Journal of Anesthesia, Vol 46, 235-239, Copyright © 1999 by Canadian Anesthesiologists' Society

ARTICLES

Clinical assessment of target-controlled infusion of propofol during monitored anesthesia care

A Casati, G Fanelli, E Casaletti, E Colnaghi, V Cedrati and G Torri
University of Milan - Department of Anesthesiology, IRCCS H. San Raffaele, Italy. casati.andrea@hsr.it

PURPOSE: To determine the plasma concentrations of propofol required to achieve different levels of sedation during monitored anesthesia care. METHODS: Sixty ASA I-II, 18-65 yr-old patients, received a target-controlled continuous iv infusion of propofol. The target plasma concentration of propofol (Cpt) was initially set at 0.4 microg x ml(-1). Two minutes after calculated equilibrium between plasma and effect-site concentrations, the Cpt of propofol was increased by 0.2 microg x ml(-1) steps until the patient showed no reaction to squeezing the trapezius. The level of sedation was assessed immediately before each increase in propofol Cpt using the Observer's Assessment of Alertness/Sedation (OAA/S) scale. RESULTS: The Cpt of propofol required to induce lethargic response to name was 1.3 microg x ml(-1) (5 degrees and 95 degrees percentiles: 1.0 - 1.8 microg x ml(-1)), to obtain response after loud and repeated calling name was 1.7 microg x ml(-1) (1.2 - 2.2 microg x ml(-1)), to obtain response after prodding or shaking was 2.0 microg x ml(-1) (1.6 - 2.6 microg x ml(-1)), to obtain response after squeezing the trapezius was 2.4 microg x ml(-1) (1.8 - 3.0 microg x ml(-1)). Patients showed no response after squeezing the trapezius at 2.8 microg x ml(-1) (2.0 - 3.6 microg x ml(-1)). Correlation between Cpt propofol and sedation scores were r = 0.76, P < 0.0001. CONCLUSIONS: Target-controlled infusion of propofol provided easy and safe management of intraoperative sedation, allowing fast and predictable deepening in the level of sedation, while minimizing systemic side effects of intravenous sedation due to the minimal risk of overdosing the drug.

This article has been cited by other articles:

				D. Hohener, S. Blumenthal, and A. Borgeat Sedation and regional anaesthesia in the adult patient Br. J. Anaesth., January 1, 2008; 100(1): 8 - 16. [Abstract] [Full Text] [PDF]

				A. Albertin, D. Poli, L. La Colla, M. Gonfalini, S. Turi, N. Pasculli, G. La Colla, P. C. Bergonzi, E. Dedola, and I. Fermo Predictive performance of 'Servin's formula' during BIS(R)-guided propofol-remifentanil target-controlled infusion in morbidly obese patients Br. J. Anaesth., January 1, 2007; 98(1): 66 - 75. [Abstract] [Full Text] [PDF]

				J. Fechner, H. Ihmsen, C. Schiessl, C. Jeleazcov, J. J. Vornov, H. Schwilden, and J. Schuttler Sedation with GPI 15715, a Water-Soluble Prodrug of Propofol, Using Target-Controlled Infusion in Volunteers Anesth. Analg., March 1, 2005; 100(3): 701 - 706. [Abstract] [Full Text] [PDF]

				D. Maltete, S. Navarro, M.-L. Welter, S. Roche, A.-M. Bonnet, J.-L. Houeto, V. Mesnage, B. Pidoux, D. Dormont, P. Cornu, et al. Subthalamic Stimulation in Parkinson Disease: With or Without Anesthesia? Arch Neurol, March 1, 2004; 61(3): 390 - 392. [Abstract] [Full Text] [PDF]

				S. Inoue, M. Kawaguchi, M. Takahashi, M. Kakimoto, T. Sakamoto, K. Kitaguchi, H. Furuya, T. Morimoto, and T. Sakaki Noxious stimuli do not modify myogenic motor evoked potentials by electrical stimulation during anesthesia with propofol-based anesthesia: [Des stimuli douloureux ne modifient pas les potentiels evoques myogenes moteurs obtenus par stimulation electrique pendant l'anesthesie a base de propofol] Can J Anesth, January 1, 2003; 50(1): 86 - 91. [Abstract] [Full Text] [PDF]

				P. Fiset, T. Paus, T. Daloze, G. Plourde, P. Meuret, V. Bonhomme, N. Hajj-Ali, S. B. Backman, and A. C. Evans Brain Mechanisms of Propofol-Induced Loss of Consciousness in Humans: a Positron Emission Tomographic Study J. Neurosci., July 1, 1999; 19(13): 5506 - 5513. [Abstract] [Full Text] [PDF]